This is mRNA 2.0. Intelligent therapies right where they’re needed.
With the power of mRNA 2.0, our pipeline programs target cancers that have resisted all other treatments, and autoimmune disorders that need pinpoint precision engineering inside the body to only T cells.
Bladder cancer, Merkel cell carcinoma, cutaneous squamous cell carcinoma, head and neck cancer
Gastric cancer, ovarian cancer, breast cancer (TNBC), small cell lung carcinoma, and bladder cancer